Vertebral artery dissection and cerebral infarction in a patient with recurrent ovarian cancer receiving bevacizumab

Gina M. Mantia-Smaldone; Linda J. Bagley; Scott E. Kasner; Christina S. Chu

doi:10.1016/j.gynor.2013.04.002

Vertebral artery dissection and cerebral infarction in a patient with recurrent ovarian cancer receiving bevacizumab

Gina M. Mantia-Smaldone, Linda J. Bagley, Scott E. Kasner, Christina S. Chu

University of Pennsylvania

Research output: Contribution to journal › Article › peer-review

8 Scopus citations

Abstract

•Ovarian cancer patients receiving bevacizumab treatment can experience significant adverse events.•We report a case of vertebral artery dissection associated with bevacizumab treatment.

Original language	English
Pages (from-to)	37-39
Number of pages	3
Journal	Gynecologic Oncology Reports
Volume	5
DOIs	https://doi.org/10.1016/j.gynor.2013.04.002
State	Published - 2013

Keywords

Adverse events
Bevacizumab
Cerebrovascular accident
Vertebral artery dissection

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.gynor.2013.04.002

Cite this

@article{be1ecd80aa8a4c65b49d64d1f140a818,

title = "Vertebral artery dissection and cerebral infarction in a patient with recurrent ovarian cancer receiving bevacizumab",

abstract = "•Ovarian cancer patients receiving bevacizumab treatment can experience significant adverse events.•We report a case of vertebral artery dissection associated with bevacizumab treatment.",

keywords = "Adverse events, Bevacizumab, Cerebrovascular accident, Vertebral artery dissection",

author = "Mantia-Smaldone, \{Gina M.\} and Bagley, \{Linda J.\} and Kasner, \{Scott E.\} and Chu, \{Christina S.\}",

year = "2013",

doi = "10.1016/j.gynor.2013.04.002",

language = "English",

volume = "5",

pages = "37--39",

journal = "Gynecologic Oncology Reports",

issn = "2211-338X",

publisher = "Elsevier B.V.",

}

TY - JOUR

T1 - Vertebral artery dissection and cerebral infarction in a patient with recurrent ovarian cancer receiving bevacizumab

AU - Mantia-Smaldone, Gina M.

AU - Bagley, Linda J.

AU - Kasner, Scott E.

AU - Chu, Christina S.

PY - 2013

Y1 - 2013

N2 - •Ovarian cancer patients receiving bevacizumab treatment can experience significant adverse events.•We report a case of vertebral artery dissection associated with bevacizumab treatment.

AB - •Ovarian cancer patients receiving bevacizumab treatment can experience significant adverse events.•We report a case of vertebral artery dissection associated with bevacizumab treatment.

KW - Adverse events

KW - Bevacizumab

KW - Cerebrovascular accident

KW - Vertebral artery dissection

UR - https://www.scopus.com/pages/publications/84877316454

U2 - 10.1016/j.gynor.2013.04.002

DO - 10.1016/j.gynor.2013.04.002

M3 - Article

C2 - 24371692

AN - SCOPUS:84877316454

SN - 2211-338X

VL - 5

SP - 37

EP - 39

JO - Gynecologic Oncology Reports

JF - Gynecologic Oncology Reports

ER -

Vertebral artery dissection and cerebral infarction in a patient with recurrent ovarian cancer receiving bevacizumab

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this